Download PDF

Register to download the report. Already a member?

Sign Up


63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Serbia Pharma Report

August 2011


Top Story


Serbia : Serbia: Ready to Flourish

Serbia has had an undoubtedly troubled history since the breakup of Yugoslavia in the early 1990s. A costly war and ensuing UN sanctions have left the country’s economy a few years behind those of its regional counterparts. The subsequent global financial crisis in the late 2000s resulted in another hit to many of the country’s key industries, including Serbia’s pharmaceutical and healthcare sectors. These historical events explain some of the key issues that underlie the sectors’ current challenges, such as non-liquidity and inadequate funding. And while Serbia’s population currently amounts to roughly 7.3 million inhabitants, ‘it is a little-known fact that 1.2 million people have no income, and that the state provides 520 dinars (roughly $7.30) per year for them,’ asserts Serbia’s Ministry of Health.

view more

snapshot in figures

Clinical trials in Serbia

  • Associations view more
  • Interviews


    Interview with Milos Bugarin , President, Serbian Chamber of Commerce

    Rather than Mr. Bugarin’s personal views, the following information contains general statements provided by the Serbian Chamber of Commerce Current trends in pharmaceutical industry The production of the medicines in all countries all around the world is one of the …

    view more

    Most Read

    Download PDF

    First Name:

    Last Name: